[go: up one dir, main page]

UA6826U - Method for treating acute experimental pancreatitis - Google Patents

Method for treating acute experimental pancreatitis

Info

Publication number
UA6826U
UA6826U UA20041209838U UA20041209838U UA6826U UA 6826 U UA6826 U UA 6826U UA 20041209838 U UA20041209838 U UA 20041209838U UA 20041209838 U UA20041209838 U UA 20041209838U UA 6826 U UA6826 U UA 6826U
Authority
UA
Ukraine
Prior art keywords
treating acute
acute experimental
dose
experimental pancreatitis
administration
Prior art date
Application number
UA20041209838U
Inventor
Serhii Mykhailovych Demydov
Volodymyr Mykhailovych Demydov
Anatolii Mykhailovy Torbynskyi
Original Assignee
Univ Odesa State Medical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Odesa State Medical filed Critical Univ Odesa State Medical
Priority to UA20041209838U priority Critical patent/UA6826U/en
Publication of UA6826U publication Critical patent/UA6826U/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The method for treating the acute experimental pancreatitis provides for intravenous administration of the liposomal form of Dalargin at a dose of 0.002-0.003 g in combination with intrabursal administration of Deltaran at a dose of 0.0009-0.0012 g and intra-arterial administration of free form of Dalargin into the celiac trunk at a dose of 0.001-0.002 g for 2-3 days.
UA20041209838U 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis UA6826U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA20041209838U UA6826U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA20041209838U UA6826U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Publications (1)

Publication Number Publication Date
UA6826U true UA6826U (en) 2005-05-16

Family

ID=34883914

Family Applications (1)

Application Number Title Priority Date Filing Date
UA20041209838U UA6826U (en) 2004-12-01 2004-12-01 Method for treating acute experimental pancreatitis

Country Status (1)

Country Link
UA (1) UA6826U (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091177A1 (en) 2007-01-18 2008-07-31 Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
EP3556377A1 (en) 2018-04-18 2019-10-23 PVP Labs PTE. Ltd. Antiviral immunotropic agent for the treatment of acute respiratory viral infections
EP3622964A1 (en) 2018-09-12 2020-03-18 PVP Labs PTE. Ltd. Agent for the treatment of skin wounds or burns

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008091177A1 (en) 2007-01-18 2008-07-31 Otkrytoe Aktsionernoe Obschestvo 'otechestvennye Lekarstva' Exenatide and dalargin-based medicinal preparation for treating pancreatic diabetes
EP3556377A1 (en) 2018-04-18 2019-10-23 PVP Labs PTE. Ltd. Antiviral immunotropic agent for the treatment of acute respiratory viral infections
EP3622964A1 (en) 2018-09-12 2020-03-18 PVP Labs PTE. Ltd. Agent for the treatment of skin wounds or burns

Similar Documents

Publication Publication Date Title
PL357944A1 (en) Intradermal-penetration agents for topical local anesthetic administration
DE69936444D1 (en) SYSTEMIC ADMINISTRATION OF SERUM-STABLE PLASMID-LIPID PARTICLES TO CANCER THERAPY
WO2005048942A3 (en) Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent
EP1355563A4 (en) METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
WO2004006906A3 (en) Methods for the treatment of neoplasms
AU1718400A (en) Method for treating pain
IL138979A0 (en) Use of cannabinoids as anti-inflammatory agents
DE60106905D1 (en) FORMULATIONS AND METHOD FOR THE USE OF NITROGEN MONOXIDE MIMETICS AGAINST A MALIGNANT CELL PHENOTYPE
WO2005058233A3 (en) Methods for treatment of acute pancreatitis
BG106057A (en) Method of enhancing the efficacy of anti-tumour agents
CY1110329T1 (en) PEGylated Liposomal Doxorubicin in Combination with Ectein Succinin 743
MY138883A (en) Use of asiatic acid for treatment of cencer
WO2004006849A3 (en) Combinations of drugs for the treatment of neoplasms
ZA200005413B (en) Cholesterol sulfate compositions for enhancement of stratum corneum function.
EP1007055A4 (en) Methods for the administration of amifostine
UA6826U (en) Method for treating acute experimental pancreatitis
UA6829U (en) Method for treating acute experimental pancreatitis
UA6828U (en) Method for treating acute experimental pancreatitis
UA6823U (en) Method for treating acute experimental pancreatitis
UA6825U (en) Method for treating acute experimental pancreatitis
MXPA03000959A (en) Combinations of dalfopristine/quinupristine with cefpirome.
AU4193800A (en) Use of tagatose to enhance key blood factors
EP1374873B8 (en) The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy
TR200000728T2 (en) The use of IFN-alpha and amantadine in the treatment of chronic hepatitis C.
EP1487427A4 (en) Methods for preventing and treating peripheral neuropathy by administering desmethylselegiline